1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Promius and Zenatane COULD Bury Absorica with one strategic move

Discussion in 'Promius Pharma' started by anonymous, Feb 16, 2017 at 11:02 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Contract direct with payers even at a lower price than your retail and ask for 1 of 2 with one of the other generics and an NDC block on Absorica

    You will overnight get the majority of payers to uptake and you will crush Absorica.

    Payers cannot stand Sun Pharma and want so bad to block Absorica. Easy flip here
     

  2. anonymous

    anonymous Guest

    Where's Zenatane now?
     
  3. anonymous

    anonymous Guest

    It's being micro managed straight out of the company just like the rest of us